P

Inventor

DOYLE ANTHONY G

AU12 patents
⚠️ This page may combine multiple inventors who share the name “DOYLE ANTHONY G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD

3 patents
US9611322B2Apr 4, 2017

Fusions of antibodies to CD38 and attenuated interferon alpha

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD6 citations81
US10981986B2Apr 20, 2021

Fusions of antibodies to CD38 and attenuated interferon alpha

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD2 citations70
US8901279B2Dec 2, 2014

Humanized antibodies with anti-tumor activity

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD0 citations47

CEPHALON INC

2 patents
US10138296B2Nov 27, 2018

Antibodies that specifically bind to TL1A

CEPHALON INC17 citations91
US11220549B2Jan 11, 2022

Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases

CEPHALON INC8 citations82

CEPHALON AUSTRALIA PTY LTD

2 patents
US7981414B2Jul 19, 2011

Anti-inflammatory dAb

CEPHALON AUSTRALIA PTY LTD0 citations48
US7846439B2Dec 7, 2010

Domain antibody construct

CEPHALON AUSTRALIA PTY LTD1 citations48

CEPHALON LLC

1 patent
US12162946B2Dec 10, 2024

Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease

CEPHALON LLC0 citations59

CLARKE ADAM WILLIAM

1 patent
US9127057B2Sep 8, 2015

Anti-IL-23 heterodimer specific antibodies

CLARKE ADAM WILLIAM2 citations57

CLARKE ADAM W

1 patent
US8470320B2Jun 25, 2013

Humanised antibodies with anti-tumour activity

CLARKE ADAM W2 citations52

WOOLVEN BENJAMIN P

1 patent
US8263076B2Sep 11, 2012

Anti-inflammatory dAb

WOOLVEN BENJAMIN P1 citations42

KIENZLE NORBERT A

1 patent
US8932588B2Jan 13, 2015

Treatment of cancer involving mutated KRAS or BRAF genes

KIENZLE NORBERT A0 citations37